• Username (E-mail)
  • Password
Dow 19,913 0.6%  EStoxx50 3,282 0.3%  Nikkei 18,788 -0.6%  EUR 1.0734 -0.3% 
Nasdaq 5,601 0.9%  FTSE100 7,150 0.0%  Yen 113.7880 1.0%  Oil 55.4 0.0% 
S&P500 2,280 0.7%  DAX 11,595 0.4%  GBP 1.2516 -0.1%  Gold 1,210 -0.8% 

Gilead Sciences share [Symbol: GILD / ISIN: US3755581036]

Realtimequote Gilead Sciences Inc. in USD

Exchange Market
70.23
Last
766,354
Volume
Time 03:59 PM
01/24/2017 03:59:59 PM UTC-0500
activate push

Stock Price Gilead Sciences Inc. in USD

Activate push
70.25 USD -0.44 USD -0.62 %
Trade Time 4:00 PM Trade Date 1/24/2017
Daily High 70.96 Open 70.60
Daily Low 69.78 Prev. Close 70.69
52-week High 103.09 Volume (Qty.) 2,572,535
52-week Low 69.78 Market Cap (USD) 94.47 B
52-week Perf.
Exchange

Analyst Opinions for Gilead Sciences Inc.

More Analyst Opinions
  • All
  • Buy
  • Hold
  • Sell
01/11/13
Gilead Sciences boerse.de-Aktienbrief
01/10/13
Gilead Sciences Aktienservice Research
12/18/12
Gilead Sciences UBS AG
12/14/12
Gilead Sciences Goldman Sachs Group Inc.
11/15/12
Gilead Sciences RBC Capital Markets

Moody's Rating for Gilead Sciences Inc.

Investment Grade (High Grade)
Investment Grade (Medium Grade)
Speculative Grade
Rating A3
Rating Update AFF
Date of Rating 5/18/2016
Rating Office USA

Profile Gilead Sciences Inc.

Company Profile
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. Its primary areas of focus include primary areas of focus include human immunodeficiency virus (HIV), liver diseases such as chronic hepatitis C virus (HCV) infection and chronic hepatitis B virus (HBV) infection, oncology and inflammation, and serious cardiovascular and respiratory conditions. Gilead Sciences was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.
pagehit

Add or Edit Instrument

Gilead Sciences Chart - 1 Year - NAS
  • Intraday
  • 1w
  • 3 Mo.
  • 1y
  • 3y
  • 5y
  • Max
  • Exchange: NAS
  • Chart Options

Estimates for Gilead Sciences

2015 2016e 2017e
Dividend 1.29 1.86 2.09
Dividend Yield in % 1.26 2.61 2.93
P/E Ratio 8.10 6.24 6.65
EPS 12.61 11.42 10.73

Gilead Sciences Key Figures

Market Cap (USD) 94.47 B
Free Float in % 99.31
Number of Shares (Mio.) 1,317.46
Cash Flow per Share 13.46
Book Value per Share 16.66
60-Days Volatility 26.6
P/B Ratio 6.13

Base Data Gilead Sciences

Symbol GILD
ISIN US3755581036
Indices NASDAQ Comp., S&P 500, NASDAQ 100, S&P 400 MidCap, S&P 100, BX Swiss - USA

About the Company Gilead Sciences

Country USA

Gilead Sciences Historical Prices

01/22/2017
01/22/2017 06:00:00 PM UTC-0500
70.69 2,327,362
01/19/2017
01/19/2017 06:00:00 PM UTC-0500
71.01 3,347,982
01/18/2017
01/18/2017 06:00:00 PM UTC-0500
71.57 3,003,680
01/17/2017
01/17/2017 06:00:00 PM UTC-0500
72.13 2,467,862
01/16/2017
01/16/2017 06:00:00 PM UTC-0500
71.91 3,584,291

Gilead Sciences Peer Group

Amgen 151.85
-0.6%
AstraZeneca 42.10
-1.0%
BB BIOTECH 52.15
-1.3%
Biogen 273.82
-0.8%
Biotest 17.01
-2.3%
Gilead Sciences 70.25
-0.6%
GlaxoSmithKline 15.20
-0.6%
Merck 61.21
-1.0%
Merck 100.55
-0.5%
Novartis 69.55
-0.6%
Pfizer 31.15
-1.0%
Roche 231.60
-0.1%
Roche 234.00
-0.4%
STADA Arzneimittel 47.40
-0.4%

Similar shares with higher 1-year perf.